News Articles Tagged: Leukemia Maintenance

Innovations in AML Care: The Promise of Venetoclax and Azacitidine for Long-Term Health

Examining the innovative use of Venetoclax and Azacitidine in intermediate-to-low-risk AML, focusing on improved survival and reduced recurrence rates through effective maintenance.

The Science of Remission: Sustaining Durability in AML with Maintenance Therapy

Explore the scientific basis and clinical impact of maintenance therapy, especially Venetoclax and Azacitidine, in achieving durable remission for intermediate and low-risk AML patients.

Understanding the Nuances: AML Relapse and the Power of Maintenance Therapy

Delve into the challenges of AML relapse and how maintenance therapy, particularly with Venetoclax and Azacitidine, offers new hope for patients with intermediate and low-risk disease.